1 245

Cited 1104 times in

International Prevalence, Recognition, and Treatment of Cardiovascular Risk Factors in Outpatients With Atherothrombosis

DC FieldValueLanguage
dc.contributor.author허지회-
dc.date.accessioned2015-06-10T12:39:28Z-
dc.date.available2015-06-10T12:39:28Z-
dc.date.issued2006-
dc.identifier.issn0098-7484-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/110210-
dc.description.abstractCONTEXT: Atherothrombosis is the leading cause of cardiovascular morbidity and mortality around the globe. To date, no single international database has characterized the atherosclerosis risk factor profile or treatment intensity of individuals with atherothrombosis. OBJECTIVE: To determine whether atherosclerosis risk factor prevalence and treatment would demonstrate comparable patterns in many countries around the world. DESIGN, SETTING, AND PARTICIPANTS: The Reduction of Atherothrombosis for Continued Health (REACH) Registry collected data on atherosclerosis risk factors and treatment. A total of 67,888 patients aged 45 years or older from 5473 physician practices in 44 countries had either established arterial disease (coronary artery disease [CAD], n = 40,258; cerebrovascular disease, n = 18,843; peripheral arterial disease, n = 8273) or 3 or more risk factors for atherothrombosis (n = 12,389) between 2003 and 2004. MAIN OUTCOME MEASURES: Baseline prevalence of atherosclerosis risk factors, medication use, and degree of risk factor control. RESULTS: Atherothrombotic patients throughout the world had similar risk factor profiles: a high proportion with hypertension (81.8%), hypercholesterolemia (72.4%), and diabetes (44.3%). The prevalence of overweight (39.8%), obesity (26.6%), and morbid obesity (3.6%) were similar in most geographic locales, but was highest in North America (overweight: 37.1%, obese: 36.5%, and morbidly obese: 5.8%; P<.001 vs other regions). Patients were generally undertreated with statins (69.4% overall; range: 56.4% for cerebrovascular disease to 76.2% for CAD), antiplatelet agents (78.6% overall; range: 53.9% for > or =3 risk factors to 85.6% for CAD), and other evidence-based risk reduction therapies. Current tobacco use in patients with established vascular disease was substantial (14.4%). Undertreated hypertension (50.0% with elevated blood pressure at baseline), undiagnosed hyperglycemia (4.9%), and impaired fasting glucose (36.5% in those not known to be diabetic) were common. Among those with symptomatic atherothrombosis, 15.9% had symptomatic polyvascular disease. CONCLUSION: This large, international, contemporary database shows that classic cardiovascular risk factors are consistent and common but are largely undertreated and undercontrolled in many regions of the world.-
dc.description.statementOfResponsibilityopen-
dc.relation.isPartOfJAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/2.0/kr/-
dc.subject.MESHAged-
dc.subject.MESHAtherosclerosis/epidemiology*-
dc.subject.MESHAtherosclerosis/therapy-
dc.subject.MESHCardiovascular Diseases/epidemiology*-
dc.subject.MESHCardiovascular Diseases/therapy-
dc.subject.MESHDrug Utilization-
dc.subject.MESHFemale-
dc.subject.MESHGlobal Health*-
dc.subject.MESHHumans-
dc.subject.MESHHydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use-
dc.subject.MESHMale-
dc.subject.MESHMiddle Aged-
dc.subject.MESHOutpatients-
dc.subject.MESHPlatelet Aggregation Inhibitors/therapeutic use-
dc.subject.MESHPrevalence-
dc.subject.MESHRegistries*-
dc.subject.MESHRisk Factors-
dc.subject.MESHThrombosis/epidemiology-
dc.subject.MESHThrombosis/therapy-
dc.titleInternational Prevalence, Recognition, and Treatment of Cardiovascular Risk Factors in Outpatients With Atherothrombosis-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Neurology (신경과학)-
dc.contributor.googleauthorDeepak L. Bhatt-
dc.contributor.googleauthorP. Gabriel Steg-
dc.contributor.googleauthorE. Magnus Ohman-
dc.contributor.googleauthorAlan T. Hirsch-
dc.contributor.googleauthorYasuo Ikeda-
dc.contributor.googleauthorJean-Louis Mas-
dc.contributor.googleauthorShinya Goto-
dc.contributor.googleauthorChiau-Suong Liau-
dc.contributor.googleauthorAlain J. Richard-
dc.contributor.googleauthorJoachim Röther-
dc.contributor.googleauthorPeter W. F. Wilson-
dc.identifier.doi10.1001/jama.295.2.180-
dc.admin.authorfalse-
dc.admin.mappingfalse-
dc.contributor.localIdA04369-
dc.relation.journalcodeJ01196-
dc.identifier.eissn1538-3598-
dc.identifier.pmid16403930-
dc.identifier.urlhttp://jama.jamanetwork.com/article.aspx?articleid=202179-
dc.contributor.alternativeNameHeo, Ji Hoe-
dc.contributor.affiliatedAuthorHeo, Ji Hoe-
dc.rights.accessRightsnot free-
dc.citation.volume295-
dc.citation.number2-
dc.citation.startPage180-
dc.citation.endPage189-
dc.identifier.bibliographicCitationJAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, Vol.295(2) : 180-189, 2006-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Neurology (신경과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.